Health Robotics reported 28 new contracts in 1Q2013, including 12 new Robots [versus 6 Robots in 1Q2012; 8 for Oncology and 4 for non-hazardous IVs] and 16 new i.v.SOFT workflow software agreements [versus 11 i.v.SOFT contracts in 1Q2012].
After a dominant record overseas with almost 300 global installations outside the USA since 2007, https://www.omnicell.com/, Health Robotics is now also the clear leader in the United States' Sterile Compounding Automation sector, with 30 Robots and 50 i.v.SOFT workflow installations, only two years after directly entering the North American market.
Gaspar DeViedma, Health Robotics' Executive Vice President and Board Member, stated: "I'm very pleased with such a strong sales-kickoff for Health Robotics in the United States this year. As predicted, Health-System pharmacists in the USA now recognize the undeniable fact that Health Robotics' second generation modular architecture of integrated and networked medical devices are fully automated, offer 3 to 4 times faster speed/throughput, for less than half the price, size, and weight than its global competitors, delivering payback periods/R.O.I. of less than 1 year, https://www.nbcnews.com/."
During the last quarter, Health Robotics and/or its sales channel network signed 28 new installations for either Batch and/or Patient-Specific Sterile Compounding Automation at: Monroe Carrell Children's Hospital at Vanderbilt University [TN], Huntsville Hospital Health System [AL], William W. Backus Hospital [CT], Kameda Hospital [Japan], Recep Tayyip Erdogan University Hospital [Rize, Turkey], Memorial Okmeydani Hospital [Istanbul], and Sisli Etfal University Hospital [Istanbul], amongst others, plus the exclusive 5-year contract with Amerinet.